The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario
<p>Abstract</p> <p>Background</p> <p>Medium chain acyl-CoA dehydrogenase deficiency (MCADD) is a disorder of mitochondrial fatty acid oxidation and is one of the most common inborn errors of metabolism. Identification of MCADD via newborn screening permits the introduct...
Saved in:
Main Authors: | Fisher Lawrence (Author), Wilson Kumanan (Author), Potter Beth K (Author), Kennedy Shelley (Author), Geraghty Michael (Author), Milburn Jennifer (Author), Chakraborty Pranesh (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2010-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening for medium-chain acyl CoA dehydrogenase deficiency: current perspectives
by: Soler-Alfonso C, et al.
Published: (2016) -
Neonatal Screening for Medium-Chain Acyl-CoA Dehydrogenase Deficiency-Alternative Approaches
by: Rodney J. Pollitt
Published: (2016) -
Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France
by: Hamers Françoise F, et al.
Published: (2012) -
Medium chain acyl-CoA dehydrogenase deficiency in a premature infant
by: Steven F. Dobrowolski, et al.
Published: (2017) -
The value of fasting in the diagnosis of medium-chain acyl-CoA dehydrogenase deficiency
by: Carmen R Vargas, et al.
Published: (2020)